63 related articles for article (PubMed ID: 26003492)
21. Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines.
Dai Q; Ling YH; Lia M; Zou YY; Kroog G; Iwata KK; Perez-Soler R
Clin Cancer Res; 2005 Feb; 11(4):1572-8. PubMed ID: 15746062
[TBL] [Abstract][Full Text] [Related]
22. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
[TBL] [Abstract][Full Text] [Related]
23. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T
Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547
[TBL] [Abstract][Full Text] [Related]
24. Comparability assessments of process and product changes made during development of two different monoclonal antibodies.
Lubiniecki A; Volkin DB; Federici M; Bond MD; Nedved ML; Hendricks L; Mehndiratta P; Bruner M; Burman S; Dalmonte P; Kline J; Ni A; Panek ME; Pikounis B; Powers G; Vafa O; Siegel R
Biologicals; 2011 Jan; 39(1):9-22. PubMed ID: 20888784
[TBL] [Abstract][Full Text] [Related]
25. Recombinant prolactin receptor extracellular domain of rainbow trout (Oncorhynchus mykiss): subcloning, preparation, and characterization.
Sandowski Y; Cohen Y; Le Rouzic P; Bignon C; Rentier-Delrue F; Djiane J; Prunet P; Gertler A
Gen Comp Endocrinol; 2000 May; 118(2):302-9. PubMed ID: 10890569
[TBL] [Abstract][Full Text] [Related]
26. Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells.
Croset A; Delafosse L; Gaudry JP; Arod C; Glez L; Losberger C; Begue D; Krstanovic A; Robert F; Vilbois F; Chevalet L; Antonsson B
J Biotechnol; 2012 Oct; 161(3):336-48. PubMed ID: 22814405
[TBL] [Abstract][Full Text] [Related]
27. CHO-recombinant human growth hormone as a protease sensitive reporter protein.
Kunert R; Steinfellner W; Altmann F; Wallner J; Katinger H; Vorauer-Uhl K
Appl Microbiol Biotechnol; 2009 Sep; 84(4):693-9. PubMed ID: 19396439
[TBL] [Abstract][Full Text] [Related]
28. Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine.
Ramírez BS; Alpízar YA; Fernández DR; Hidalgo GG; Capote AR; Rodríguez RP; Fernández LE
Vaccine; 2008 Sep; 26(38):4918-26. PubMed ID: 18672015
[TBL] [Abstract][Full Text] [Related]
29. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
[TBL] [Abstract][Full Text] [Related]
30. Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility.
Ghedini GC; Ciravolo V; Tortoreto M; Giuffrè S; Bianchi F; Campiglio M; Mortarino M; Figini M; Coliva A; Carcangiu ML; Zambetti M; Piazza T; Ferrini S; Ménard S; Tagliabue E; Pupa SM
J Cell Physiol; 2010 Oct; 225(1):256-65. PubMed ID: 20506359
[TBL] [Abstract][Full Text] [Related]
31. Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells using vaccinia virus.
Davis KM; Brigstock DR; Johnson PR; Crissman-Combs MA; McCarthy DW; Downing MT; Besner GE
Protein Expr Purif; 1996 Aug; 8(1):57-67. PubMed ID: 8812835
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer protein StarD10 identified by three-dimensional separation using free-flow electrophoresis, reversed-phase high-performance liquid chromatography, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Hoffmann P; Olayioye MA; Moritz RL; Lindeman GJ; Visvader JE; Simpson RJ; Kemp BE
Electrophoresis; 2005 Mar; 26(6):1029-37. PubMed ID: 15704244
[TBL] [Abstract][Full Text] [Related]
34. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
35. Expression and Characterization of the Extracellular Domain of Human HER2 from Escherichia Coli, and Production of Polyclonal Antibodies Against the Recombinant Proteins.
Sun Y; Feng X; Qu J; Han W; Liu Z; Li X; Zou M; Zhen Y; Zhu J
Appl Biochem Biotechnol; 2015 Jun; 176(4):1029-43. PubMed ID: 25906688
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of monoclonal antibodies specific for the murine thyrotropin receptor.
Davies TF; Bobovnikova Y; Weiss M; Vlase H; Moran T; Graves PN
Thyroid; 1998 Aug; 8(8):693-701. PubMed ID: 9737366
[TBL] [Abstract][Full Text] [Related]
37. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
Huang WC; Hsu RM; Chi LM; Leu YL; Chang YS; Yu JS
Cancer Lett; 2007 Apr; 248(1):137-46. PubMed ID: 16919867
[TBL] [Abstract][Full Text] [Related]
38. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
[TBL] [Abstract][Full Text] [Related]
39. Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells.
Adamczyk KA; Klein-Scory S; Tehrani MM; Warnken U; Schmiegel W; Schnölzer M; Schwarte-Waldhoff I
Life Sci; 2011 Aug; 89(9-10):304-12. PubMed ID: 21763319
[TBL] [Abstract][Full Text] [Related]
40. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
